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the RV complex shape. Data regarding RV performance in patients with diabetes are incomplete
The aim of this study was to assess the feasibility of pulsed wave tissue Doppler imaging and myo-
cardial performance index (MPI) for the assessment of right ventricular function in diabetic patients
without coronary artery disease.
Methods: The study included 20 diabetic patients, 20 diabetic hypertensive and 20 gender and age
matched healthy subjects underwent standard echocardiography with tissue Doppler imaging (TDI)
to assess RV function. Patients with myocardial ischemia, impaired left ventricular systolic func-
tion, valvular heart disease or other diseases which could alter the right ventricular performance
were excluded.
Results: Myocardial performance index was signiﬁcantly higher in diabetes compared to control
group (0.41 ± 0.05 versus 0.27 ± 0.04, p= 0.001). Peak myocardial systolic velocity (Sa), early
diastolic myocardial velocity (Ea), and late diastolic myocardial velocity (Aa) were signiﬁcantly
lower in patients with diabetes mellitus (DM) compared to the control group (p= 0.0001). Isovol-
umetric relaxation time (IVRT) was signiﬁcantly higher in DM group compared to control group
(p= 0.003). MPI was signiﬁcantly higher in diabetic hypertensive group versus DM alone group
(0.46 ± 0.050 versus 0.41 ± 0.05, p= 0.01). There was no correlation between MPI and blood glu-
cose level and duration of diabetes.0 502374373; mobile: +20
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176 A.A. Abdelaziz, E.M. DaoudConclusion: Myocardial performance index is a useful noninvasive tool for the detection of early
right ventricular systolic and diastolic dysfunction in diabetic patients, regardless of coexisting
hypertension.
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The right ventricle (RV) is neglected in clinical practice, be-
cause there is lack of awareness of its pivotal role in cardiac
and pulmonary vascular diseases.1
Right ventricular function is the primary determinant of
prognosis and effort tolerance in many groups of patients.
Clinicians require measures that are widely available, easily
obtained, highly reproducible, and provide clear information
on prognosis, likely response to therapy or provide feedback
on the success of therapeutic interventions. However RV func-
tion is notoriously difﬁcult to evaluate, given its geometry,
interrelationship with the left ventricle and sensitivity to alter-
ations in pulmonary pressure.1
In patients with left ventricular failure, myocardial infarc-
tion and pulmonary hypertension, RV function is an impor-
tant predictor of mortality and quality of life.2
The majority of proposed methods of echocardiographic
assessment of RV function are based on volumetric approxi-
mations of the RV. Such approaches have inherent limitations,
ﬁrst as volume related measures such as ejection fraction (EF)
are load dependent; second because of the complex geometry
of RV.3
The issue of RV geometry is usually overcome using geom-
etry-independent parameters such as tricuspid annular velocity
and Tei index. Tei index is calculated using Doppler as the ra-
tio of the isovolumic contraction and relaxation times to the
ejection time.1
The volume calculation and estimation of EF are not ideal
for the clinical assessment of RV function; however, regional
myocardial wall motion detection by M-Mode and tissue
Doppler velocities is probably the most useful method in clin-
ical practice.4
Diabetes mellitus (DM) is a powerful risk factor for cardio-
vascular disease associated with high morbidity and mortality
rates. Diabetic patients also have an increased incidence of
heart failure which has been traditionally attributed to concur-
rent presence of ischemic or hypertensive heart disease. Yet,
nowadays, according to recent scientiﬁc evidence, diabetic
myocardial disease (DMD) is more and more being considered
as a distinct nosologic entity, independent of the co-existence
of CAD, arterial hypertension or other risk factors, with the
potential to lead to a self-existent progressive development of
heart failure.5
The vast majority of previous reports regarding myocar-
dial dysfunction in patients with diabetes mellitus were ded-
icated to the left ventricle, ignoring the role of the RV.
However, it is unlikely that the pathological sequel of meta-
bolic disarrangements in diabetes spares the right sided
myocardium.6
2. Aim of the work
This study was designed to assess the feasibility of pulsed wave
tissue Doppler imaging and myocardial performance index(MPI) for the assessment of right ventricular function in dia-
betic patients without coronary artery disease.
3. Patients and methods
3.1. Study populations
This study was carried out on 40 patients (test group) with dia-
betes mellitus, selected from outpatient cardiovascular clinic,
Mansoura specialized medical hospital, Mansoura University,
Egypt, during the period January 2010 –September 2010.
The test group is classiﬁed into:
 Group I: 20 patients with diabetes and normal blood
pressure (DM group) (mean age 54.1 ± 4.96 years).
 Group II: 20 patients with coexisting diabetes and hyper-
tension (DM HTN group) (mean age 56.0 ± 4.16 years).
The control group (group III) includes 20 healthy subjects
(mean age 54.9 ± 3.99 years).
3.2. Exclusion criteria
- Coronary artery disease was excluded according to clin-
ical, electrocardiographic (basal, exercise stress test),
echocardiographic characteristics of myocardial ische-
mia. In about 22 patients, coronary angiography was
normal.
- Rheumatic and congenital heart disease.
- Atrial ﬁbrillation.
- Impaired LV systolic function (EF < 50%).
- Impaired hepatic or renal function, and advanced lung
disease.
- Pulmonary hypertension.
- Patients with more than grade I tricuspid regurgitation.
- Patients with bad quality of echocardiographic imaging
of the tricuspid annular motion.
Both test and control groups were subjected to clinical
assessment, electrocardiography (ECG), laboratory, Doppler
echocardiography (conventional and pulsed wave tissue Dopp-
ler imaging ‘‘PW-TDI’’).
3.3. Clinical assessment
All patients were subjected to thorough history taking; full
physical examination with special focus on age, sex, duration
and therapy of diabetes, blood pressure and body mass index
(kg/m2).
3.4. Echocardiography
All patients and control groups underwent echocardiographic
examination. Complete two-dimensional, M-mode and
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apical and subcostal approaches with GE (vivid 3 pro) NOR-
WAY, using 2.5 MHz multifrequency transducer.
Two-dimensional, M-mode echocardiography in order to
measure left and right ventricular dimensions and wall thick-
ness, left ventricular ejection fraction measured by modiﬁed
Simpson’s biplane method.
The RV free wall thickness, normally less than 0.5 cm is
measured from the subcostal view using either M-mode or
two-dimensional imaging.3 End-diastolic and end-systolic RV
diameters were measured in the modiﬁed low parasternal
view.3
Conventional Doppler echocardiography is used to mea-
sure left and right ventricular parameters of diastolic function
(early (E) and late (A) peak diastolic ﬂow velocity, E/A ratio
and isovolumic relaxation time (IVRT).
3.5. Tissue Doppler echocardiography
Using the four chamber view, a sample volume was placed at
the lateral side of the tricuspid annulus. Care was taken to ob-
tain an ultrasound beam parallel to the direction of the tricus-
pid annular motion. The peak systolic myocardial velocity
(Sa), peak early diastolic myocardial velocity (Ea), and late
diastolic myocardial velocity (Aa) at the time of atrial contrac-
tion were determined (Figs. 1 and 2). On TDI, the time interval
from the end to the onset of tricuspid annular velocity pattern
during diastole (a) is equal to the sum of isovolumic contrac-
tion time (ICT), isovolumic relaxation time (IRT), and ejec-
tion time (ET). ET (b) was measured as the duration of Sa
wave.
Myocardial performance index (MPI) was calculated as fol-
lows: (isovolumic contraction time + isovolumic relaxation
time)/RV ejection time or (ab)/b. The mean normal value
of the Tei index is 0.39 ± 0.05 for the LV,7 while for the right
ventricle (RV) it is 0.28 ± 0.04.8 In adults, values of the LV in-
dex < 0.40 and for the RV < 0.30 are considered normal.
All pulsed Doppler tissue imaging parameters were
measured on 4–6 consecutive heart cycles and mean value
was calculated.Figure 1 Pulsed wave tissue Doppler imaging of the lateral
tricuspid annulus of diabetic patient. 1: peak myocardial systolic
velocity (Sa), 2: peak early diastolic velocity (Ea), 3: peak late
diastolic velocity (Aa).3.6. Statistical analysis
Data are expressed as mean ± S.D, and frequencies are
expressed as percentages. Differences between groups were as-
sessed by Student’s unpaired t-test. Categorical variables were
compared using v2 test. Pearson’s correlation coefﬁcients were
calculated for pairs of continuous variables. A two-tailed p-va-
lue < 0.05 was considered signiﬁcant. Statistics were calcu-
lated by software (SPSS, Version 17.0, SPSS Inc., Chicago,
IL).
4. Results
The clinical characteristics data are listed in Table 1. There was
no signiﬁcant difference between DM and control group as
regards the age, sex, blood pressure and BMI, while BMI
was signiﬁcantly higher in DM HTN group when compared
with either diabetes alone group or control group
(27.7 ± 1.6 versus 25.9 ± 2.2, 25.7 ± 2.26; p = 0.005, 0.003,
respectively).
The left and right ventricular echocardiographic ﬁndings in
diabetic patients and controls are summarized in Table 2, there
was no signiﬁcant difference as regards the right ventricular
end-diastolic diameter (RVEDD), RV free wall thickness, left
ventricular end diastolic diameter (LVEDD), and LV mass
in diabetics versus control group. On the other hand, diabetic
patients have lower LV EF (64.2 ± 2.51 versus 68.0 ± 3.79;
p = 0.001), and lower early ﬁlling velocity-to-atrial contrac-
tion velocity (E/A) ratios (1.16 ± 0.18 versus 1.32 ± 0.19;
p= 0.01).
The parameters derived from pulsed wave myocardial TDI
at the level of tricuspid annulus are listed in Table 3. The peak
systolic velocity (Sa), early diastolic (Ea), late diastolic velocity
(Aa) were signiﬁcantly lower in diabetic patients when
compared with the control group (p= 0.0001); while the
isovolumic relaxation time (IVRT) was signiﬁcantly higher in
diabetes mellitus group. When we compared DM versus DM
HTN group, only the peak systolic velocity was signiﬁcantly
lower in DM group (p= 0.006) with no signiﬁcant difference
in early, late diastolic velocity, and IVRT.Figure 2 Pulsed wave tissue Doppler imaging of the lateral
tricuspid annulus of control patient. 1: peak myocardial systolic
velocity (Sa), 2: peak early diastolic velocity (Ea), 3: peak late
diastolic velocity (Aa).
Table 1 Clinical characteristics of the studied patients.
DM group
(n= 20)
DM HTN
group (n= 20)
Control
group (n= 20)
DM versus
DM HTN
DM versus
control
DM HTN
versus control
Age (years) 54.1 4.96 56.0 4.16 54.9 3.99 NS NS NS
Sex (male) 12 60% 13 65% 11 55% NS NS NS
DM duration (years) 10.2 2.83 9.9 3.05 – – NS – –
DM type (II) 18 90% 17 85% – – NS – –
SBP (mmHg) 123.5 6.0 144.7 7.1 121.7 4.94 0.0001 NS 0.0001
DBP (mmHg) 78.0 5.71 93.7 5.0 79.2 6.12 0.0001 NS 0.0001
FBS (mg/dl) 148.2 6.2 146.5 5.4 82.5 10.5 NS 0.0001 0.0001
BMI (kg/m2) 25.9 2.2 27.7 1.6 25.7 2.26 0.005 NS 0.003
BMI = body mass index, DBP = diastolic blood pressure, DM= diabetes mellitus with normal blood pressure, DM HTN= diabetes mellitus
and hypertension group, FBS = fasting blood sugar, NS = no signiﬁcant difference, SBP = systolic blood pressure. Data are means ± S.D.
Table 2 Comparison of conventional echocardiographic data in different groups.
DM group
(n= 20)
DM HTN
group (n= 20)
Control group
(n= 20)
DM versus
DM HTN
DM versus
control
DM HTN
versus control
RVEDD (cm) 1.91 21 1.89 0.17 1.89 0.15 NS NS NS
RV free wall (cm) 0.31 0.039 0.30 0.031 0.30 0.026 NS NS NS
LVEDD (cm) 4.88 0.20 4.94 0.31 4.83 0.17 NS NS NS
IVST (cm) 0.99 0.11 1.43 0.15 1.0 0.11 0.0001 NS 0.0001
PWT (cm) 0.95 0.08 1.37 0.24 0.89 0.09 0.0001 0.038 0.0001
EF (%) 64.2 2.51 65.8 4.19 68.0 3.79 NS 0.001 NS
LV mass (g/m2) 102.8 10.2 137.7 12.3 98.5 9.28 0.0001 NS 0.0001
E/A ratio 1.16 0.18 1.11 0.16 1.32 0.19 NS 0.01 0.001
EF = ejection fraction, IVST= interventricular septal thickness, LVEDD= left ventricular end-diastolic diameter, NS = no signiﬁcant dif-
ference, PWT= posterior wall thickness, RVEDD= right ventricular end-diastolic diameter.
Table 3 Comparison of tricuspid annular velocity pulsed wave tissue Doppler data in different groups.
DM
group (n= 20)
DM HTN
group (n= 20)
Control
group (n= 20)
DM versus
DM HTN
DM versus
control
DM HTN
versus control
Sa (cm/s) 11.42 0.81 12.11 0.68 12.8 0.79 0.006 0.0001 0.002
Ea (cm/s) 8.53 0.67 8.38 0.58 10.9 0.85 NS 0.0001 0.0001
Aa (cm/s) 9.29 0.68 9.26 0.73 10.8 0.69 NS 0.0001 0.0001
IVRT (ms) 51.30 7.24 50.35 7.63 43.2 8.68 NS 0.003 0.009
Aa = late diastolic myocardial velocity, Ea = early diastolic myocardial velocity, IVRT= isovolumetric relaxation time, Sa = peak systolic
myocardial velocity.
Table 4 Comparative analysis of myocardial performance index in different groups.
DM group
(n= 20)
DM HTN group
(n= 20)
Control group
(n= 20)
DM versus
DM HTN
DM versus
control
DM HTN
versus control
MPI 0.418 0.052 0.462 0.050 0.273 0.048 0.01 0.0001 0.0001
MPI = myocardial performance index.
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signiﬁcantly higher in diabetic group (0.418 ± 0.052 versus
0.273 ± 0.048; p = 0.0001), and DM HTN group versus con-
trol group (0.462 ± 0.050 versus 0.273 ± 0.048; p = 0.0001,
Table 4). RV MPI was signiﬁcantly higher in DM HTN group
when compared with DM alone group (p= 0.01). No signiﬁ-
cant correlation between RV MPI and either DM duration
and fasting blood glucose levels (Figs. 3 and 4).5. Discussion
The right ventricle has an important contribution to the over-
all cardiac function, but contrary to the LV, data regarding the
RV function in diabetics are still rather incomplete.6
Echocardiography is less accurate in the evaluation of right
ventricular ejection fraction because of the complex right
ventricular shape, and load dependence of its ejection fraction
Figure 3 Correlation between myocardial performance index
and the duration of diabetes.
Figure 4 Correlation between myocardial performance index
and fasting blood sugar level.
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determining the tricuspid annular excursions and velocities
reﬂecting the function of longitudinally oriented myocardial
ﬁbers which contribute to the right ventricular ejection more
than circularly oriented ﬁbers.9
Tei et al.8 proposed a Tei index (or myocardial performance
index (MPI), obtained from the Doppler time intervals, which
allows simple noninvasive and non-geometric estimation of
global ventricular functions. Myocardial performance index
is deﬁned as the ratio of the sum of the isovolumic contraction
and the isovolumic relaxation times divided by the ventricular
ejection time and can be measured for both the left and right
ventricles.10,11
A number of studies have documented that the Tei index is
independent of arterial pressure,12,13 heart rate,7,14 ventricular
geometry, atrioventricular valve regurgitation,7,8 afterload,15
and preload in patients who are in a supine position.16
It has been found to have prognostic value for various
cardiac conditions.8,13 Yeo et al. reported doppler right
ventricular index to be a useful noninvasive parameter that
correlates with symptoms and survival in patients with primary
pulmonary hypertension.17 Some authors found a negative
correlation between RV MPI and RV EF, but other authors
failed to do so. Hori et al. conﬁrmed correlations with dP/dt.18
The aim of the study was to assess the feasibility of pulsed
wave tissue Doppler imaging and myocardial performance
index (MPI) for the assessment of right ventricular function
in asymptomatic diabetic patients without coronary artery
disease.
Tissue Doppler derived peak systolic velocities of tricuspid
annular motion (Sa) being signiﬁcantly lower in diabetic
patients in this study is a useful tool to determine early right
ventricular systolic dysfunction in patients with diabetes
whereas right ventricular dimension and RV free wall thick-
ness did not differ signiﬁcantly from the control group
(Table 3).
Systolic velocity of tricuspid annular motion correlates well
with MRI-derived RVEF.19 Meluzin et al. showed that an Svelocity less than 11.5 cm/s was predictive of an RVEF less
than 45% with a sensitivity of 90% and a speciﬁcity of 85%
created three levels of S velocity (<9, 9–12 and >12 cm/s)
to distinguish three levels of RVEF (<30, 30–55 and >55%).9
The diabetic group shows impairment of RV diastolic func-
tion, which was indicated by TDI lower values of Ea, Aa, and
longer isovolumic relaxation time (Table 3). However the exact
relation of the diastolic tricuspid annular velocities to the
severity of the RV diastolic dysfunction has not yet been
assessed and should be clariﬁed in the future studies.
Mytas et al. revealed that diabetic patients have impaired
diastolic function in both ventricles either conventional or
tissue Doppler echocardiography.5 Caso et al. reported the
gradual increase in regional myocardial IVRT in parallel with
the increase in pulmonary artery pressure.20
It has been reported that DM causes subclinical LV
dysfunction. RV function could be affected by an impaired left
ventricular function. Hence, left ventricular function was ana-
lyzed in diabetic patients and control group and was found
that diabetic patients have signiﬁcantly lower LV EF and E/
A ratio (Table 2).
The involvement of both ventricles in DM patients, suggest
that diabetes causes a global toxic effect on myocardial cells.
Also the close correlation of the two ventricles as well as the
sharing of the interventricular septum, pericardium and ven-
tricular interdependence may have a role.21,225.1. HTN and DM
In our study diabetic patients without hypertension have lower
tricuspid annular peak systolic velocity when compared with
diabetes and hypertension with no signiﬁcant difference in
PW-TDI diastolic parameters in diabetic patients with and
without HTN (Table 3). These results suggest that the contrib-
uting effect of hypertension on RV function in diabetic
patients is not more than the effect of diabetes alone on RV
function. This is concordant with Kosmola et al., who do
not ﬁnd any contributing effect of coexisting hypertension to
RV dysfunction in contrast to the LV. The adverse inﬂuence
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nently exposed to the pressure overload. Kosmola also shows
no signiﬁcant increase in RV free wall thickness.6
In our study there was no signiﬁcant difference in LVEF
and E/A ratio between non-hypertensive diabetics group and
diabetic hypertensive group (Table 2). This contradictory data
may be attributed to small number of patients’ study.
Various studies, including those from the Framingham
database, have reported that up to 80% of diabetes subjects
have hypertension. Hypertension accelerates diastolic and
systolic dysfunction in diabetes and increases mortality by
more than 7-fold as compared with non-hypertensive diabetics.
Data from the Strong Heart Study and others have revealed
the independent effect of diabetes on indices of left ventricular
systolic function. Compared with non-diabetics, subjects with
diabetes had greater left ventricular mass and lower left
ventricular fractional shortening.23
5.2. Myocardial performance index (MPI)
The signiﬁcant difference in MPI between diabetics and con-
trol group is indicative of the impairment of both RV systolic
and diastolic functions in non-hypertensive diabetics and
diabetic hypertensive patients (Table 4). In systolic dysfunc-
tion, the isovolumic contraction time increases, whereas the
ejection time decreases and, consequently, the MPI increases.
In diastolic dysfunction, there is prolongation of the isovolu-
mic relaxation time that also results in an increased MPI.
We calculate the RV myocardial performance index at the
lateral annulus of the tricuspid valve by pulsed Doppler tissue
imaging with the advantage of being measured at the same site
during the same cycle.10
Karamitsos et al. show that type 1 diabetic patients were
found to have impaired diastolic function in both ventricles
with either conventional or tissue Doppler echocardiography.
On the contrary, systolic function in both ventricles was
preserved.24
Kosmala et al. reported right ventricular diastolic dysfunc-
tion in type I and type II diabetic using TDI although conven-
tional Doppler failed to show any difference in E/A ratio
among diabetic patients and normal subjects. All the groups
did not differ in RV systolic function as expressed by tricuspid
plane systolic excursion and Sa in the basal and mid-segments
of the RV.25
Kosmola et al. demonstrated subclinical RV dysfunction by
the strain/strain rate technique in diabetics.6
Wang et al. determined which echocardiographic variables
best correlated with RV ejection fraction as assessed by cardiac
magnetic resonance imaging (cMRI) and found that right
ventricular fractional area change, Tei index, isovolumic accel-
eration were the best correlated variables.26
So in patients with early subclinical diabetic heart disease,
myocardial dysfunction is not conﬁned to the left ventricle,
but also involves the right ventricle, and the impairment of
RV function encompasses both systolic and diastolic
abnormalities.
The pathophysiological background of cardiac dysfunction
in diabetes is multifactorial and may include both functional
and structural alterations in heart muscle.
Disturbances of myocardial carbohydrate and lipid metab-
olism with intracellular accumulation of triglycerides and toxic
fatty acid intermediates, reduced adenosine triphosphataseactivity and abnormalities of sarcoplasmic reticulum and sar-
colemmal calcium transport may be responsible for functional
myocardial disarrangement.27 Nonetheless, decreased myocar-
dial function may also result from structural changes, namely
damage of myoﬁbrils, transverse tubules and other micro-
structural elements, as well as cardiomyocyte apoptosis and
necrosis provoked by hyperglycemia, reactive oxygen species
and increased concentration of angiotensin II. Loss of cardio-
myocytes may in turn produce replacement ﬁbrosis leading to
myocardial stiffness and thus abnormal diastolic properties.28
The additional causative factors of impaired cardiac perfor-
mance in diabetes are thought to be microangiopathy and
autonomic neuropathy and the independent effect of insulin
resistance, and its link with altered myocardial substrate
metabolism and contractile function.28
Hyperglycemia induced activation of protein kinase C has
been implicated in some of the maladaptive changes seen at
the cellular level in diabetes. Protein kinase C activation leads
to changes in contractile protein function, stimulation of
angiotensin-converting enzymes (ACE) genes and inducible
nitric oxide synthase activity. Elevated ACE activity leads to
many of the maladaptive changes in diabetes.29
In the present study, we have not found signiﬁcant correla-
tion between the duration of diabetes, blood glucose level and
the RV MPI (Figs. 3 and 4), which is in contrary to the ﬁnd-
ings of Karamitsos et al.24 In spite of this the signiﬁcant impact
of hyperglycemia on myocardial function cannot be ignored.
An association of HbA1c with estimates of LV dysfunction
was demonstrated in some but not all previous studies.23
Our results were similar to Radulescu et al., who showed
altered right ventricular diastolic performance in patients with
metabolic syndrome with no correlation between blood glu-
cose levels and degree of impairment.30
This study has some limitations. One is that the RV systolic
function was evaluated with transthoracic echocardiography.
Other more accurate and objective methods to estimate RV
systolic function, such as MRI or RV angiography, would
have increased this study’s reliability. The other limitation is
the study’s small population. Also data from large scale epide-
miological studies regarding the application of Tei index are
lacking. Finally, coronary angiography was not done in all
the patients.
6. Conclusion
Myocardial dysfunction in patients with diabetes mellitus is
not conﬁned to the left ventricle, but also involves the right
ventricle, and the impairment of RV function encompasses
both systolic and diastolic abnormalities, regardless of coexis-
ting hypertension. Tissue Doppler right ventricular myocardial
performance index is a useful noninvasive tool for early detec-
tion of RV dysfunction in diabetics.References
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